Summary. Background: Progressive, restrictive, respiratory insufficiency is the major cause of morbidity and mortality in Congenital Muscular Dystrophy (CMD). Nocturnal hypoventilation precedes daytime alveolar hypoventilation, and if untreated, may lead to respiratory failure and cor pulmonale. CMD consensus care guidelines recommend screening for respiratory insufficiency by conventional and dynamic (sitting to supine) pulmonary function testing (PFT) and evaluating for sleep disordered breathing if there is more than 20% relative reduction from sitting to supine FVC(L) (DFVC). Objective: The objective of this retrospective study was to explore and characterize dynamic FVC measures in 51 individuals with two common subtypes of CMD, COL6-RD, and LAMA2-RD. Methods: We compared sitting and supine FVC in patients with confirmed mutation(s) in either COL6 or LAMA2. We investigated influences of age, CMD subtype, gender, race, ambulatory status, and non-invasive positive pressure ventilation (NIPPV) status on FVC percent predicted (FVCpp) and DFVC. Results: COL6-RD participants exhibited a significant difference between sitting and supine mean FVCpp (sitting 66.1, supine 55.1; P < 0.0001) and were 5.4 times more likely to have ÀDFVC >20% than those with LAMA2-RD when controlling for ambulant status. FVCpp sitting correlated inversely with age in individuals 18 years. Conclusion: FVCpp sitting decreases progressively in childhood in both CMD subtypes. However, our results point to a difference in diaphragmatic involvement, with COL6-RD individuals having more disproportionate diaphragmatic weakness than LAMA2-RD. A DFVC of greater than À20% should continue to be used to prompt evaluation of sleep-disordered breathing. Timely initiation of NIPPV may be indicated to treat nocturnal hypoventilation.
INTRODUCTION
Congenital muscular dystrophies (CMD) comprise a group of phenotypically and genetically heterogeneous disorders characterized by progressive, early onset muscle weakness, axial, and peripheral skeletal contractures, and progressive respiratory insufficiency evidenced by a predictable annual rate of decline in forced vital capacity (FVC). [1] [2] [3] [4] Progressive, restrictive pulmonary defect is the major cause of morbidity and mortality in CMD. Nocturnal hypoventilation often precedes daytime respiratory insufficiency, and if untreated, may lead to respiratory failure and cor pulmonale. 3 This respiratory insufficiency primarily stems from the combination of progressive muscle weakness, thoracic deformity, decreased compliance of the chest wall and lungs, and costo-vertebral limitation. [4] [5] [6] [7] [8] [9] Pulmonary function screening allows for earlier detection and treatment of nocturnal alveolar hypoventilation, especially when ambulatory status may not correspond to the degree of respiratory limitation. 1, 2, 10 To identify individuals at risk, the 2010 CMD consensus care guidelines suggest screening for respiratory insufficiency by conventional and dynamic (sitting to supine) pulmonary function testing (PFT) in ambulant and nonambulant individuals with CMD. 2 To further identify early sleep-disordered breathing, these guidelines also recommend nocturnal oximetry be performed if there is a >À20% relative change from sitting to supine FVC(L) (DFVC) and FVC percent predicted sitting (FVCpp) is <80%, or if FVCpp sitting alone is <60% predicted. 2 Nocturnal oximetry was recommended by Wang et al., 2 because polysomnography (PSG) is not always available. However, the gold standard to assess sleep disordered breathing, including hypoventilation and hypercapnea, involves PSG or the use of nocturnal oximetry with capnography because both O 2 and CO 2 readings may be required to make informed decisions about a potential intervention. In addition, the CMD standard of care recommendations do not yet address specific CMD subtype differences because there currently is insufficient specific data. The use of non-invasive positive pressure ventilation (NIPPV) to correct nocturnal hypoventilation has resulted in improved survival and quality of life in various neuromuscular disorders. 1, 2, 11, 12 Recent retrospective cohort studies in two CMD subtypes, Collagen VI-related dystrophy (COL6-RD) and Selenoprotein N,1 (SEPN1)-related myopathy, highlight the potential need for NIPPV even in ambulant individuals. 4, 13 CMD subtypes present with differing phenotypic spectra. In COL6-RD, the phenotype ranges from a severe Ullrich CMD presentation to the mild Bethlem Myopathy. Ullrich CMD presents with either the inability to achieve ambulation or a loss of ambulation at a mean age of 10 years (typical Ullrich CMD, or "moderate progressive"). 14 In the intermediate form of COL6-RD "mild,"
14 individuals achieve ambulation but do not run or hop, lose ambulation at a mean age of 19 years, and may develop respiratory insufficiency while still ambulant. In the mildest phenotype, Bethlem Myopathy, individuals can achieve and maintain ambulation through adulthood. 4 In laminin alpha 2-related dystrophy (LAMA2-RD), individuals with complete deficiency of laminin alpha 2 (or complete merosin deficiency) typically do not achieve ambulation. 1, 2, 11 Individuals with partial deficiency of laminin alpha 2 have a more variable phenotype in regard to pattern of weakness and may achieve ambulation. 15 Studies describing pulmonary function in specific CMD subtypes are limited. Although some neuromuscular disorders may behave similarly, a varying degree of involvement of distinct respiratory and abdominal muscles may be subtype-specific and account for different rates of decline in FVC. 4, 8, 13, 16, 17 The diaphragm is the most important muscle involved in respiration and is affected by posture. In the seated position, the diaphragm contributes approximately 70% to tidal breathing and the intercostal muscles approximately 30%. However, in the supine position, the diaphragm contribution can increase to nearly 90%. 18, 19 An excessive fall in FVC from sitting to supine thus is a good indicator of diaphragm weakness, even in subjects who might have global inspiratory muscle dysfunction. 20 Thus, individuals with neuromuscular disorders in which the diaphragm is selectively involved are at greater risk for nocturnal hypoventilation. FVC is commonly used to evaluate respiratory muscle strength in patients with these disorders. 21 Variables that influence FVC include age, weight, height, gender, race, ambulatory status, and NIPPV status. The objective of our retrospective study was to explore and characterize FVC measures in the sitting and supine positions of individuals with COL6-RD and LAMA2-RD, and we hypothesized that there is a relationship between the decrease in DFVC and NIPPV status in both disease subtypes. 
MATERIALS AND METHODS

This
Demographics
Demographic variables are recorded in Table 1 . Compared with LAMA2-RD, more COL6-RD participants were >18 years of age (P ¼ 0.04) and ambulatory (P ¼ 0.0002) (see Table 1 ). Of the participants with COL6-RD, 22 (73%) were ambulatory, and 5 (42%) of the COL6-RD participants with FVCpp <60% were ambulatory. In contrast, four (21%) of LAMA2-RD participants were ambulatory, and none of LAMA2-RD participants with FVC <60% were ambulatory. There were no significant differences in race, gender, or NIPPV status between the two subtypes.
All PFTs were performed in the Pulmonary Function Laboratory of the National Heart, Lung, and Blood Institute at the National Institutes of Health using the VMAX TM Encore PFT system, software v. 21.1A; CareFusion Corporation, San Diego, CA, as part of an annual evaluation of participants in the above protocols. ATS/ERS guidelines were followed. 22 Testing included FVC in the sitting and supine positions, with results reported in both absolute values (in liters, L) and FVCpp using established reference equations. 23, 24 Participants completed spirometry in the sitting position first, then in the supine position. Approximately, 10-30 min elapsed between tests to allow for recovery and to minimize fatigue. Standing height was measured for participants who were capable of standing and were without contractures. For individuals with lower extremity contractures or who could not stand, a Rosscraft segmometer was used to measure the ulna length, and height was consequently derived. 25 Ambulatory status was defined as the ability to walk 10 m without orthotics or assistive devices. NIPPV status was defined as the use of non-invasive mechanical ventilatory support as either <16 hr per day, or >16 hr per day.
Descriptive analyses were performed with calculation of means, standard deviations and medians for continuous variables. Categorical variables were summarized using frequencies and percentages. Descriptive analyses were implemented using SPSS Statistics 19; all other analyses were implemented in SAS 9.3. Fisher's exact test was used to identify significant differences between COL6-RD and LAMA2-RD with respect to categorical variables (Table 1) .
Multivariate Analysis of Covariance (MANCOVA) was used to compare FVC in sitting and supine positions, Percentages of category subsets in parenthesis; percentages based on disease subtypes. Totals for each category in the right-hand column; totals by disease at bottom. Fisher exact test was used to examine the differences in characteristics between the COL6-RD and LAMA2-RD group. The majority of subjects were age 18 years or younger, were Caucasian, and were non-ventilated. The number of males and females was nearly equal, and the number of ambulant/non-ambulant subjects was also equal. Between the two subtypes, there were significantly more adults with COL6-RD than with LAMA2-RD. There was also a significant difference in ambulatory status between the two subtypes (COL6-RD had more ambulant individuals We performed Pearson correlations to assess the relationship between each FVC measure and age. A partial Pearson correlation was performed to determine the association between DFVC and age while adjusting for sitting FVCpp, which served as the "baseline" FVC in this study. Because of the significant difference in the number of adults between the two subtypes, all Pearson correlations included the total n ¼ 51 and were also subdivided for subjects by age 18 versus >18 years.
We performed logistic regression to determine how the odds of having ÀDFVC >20% may be impacted by ambulatory or NIPPV status.
Multiple linear regression was used to analyze the relationship between DFVC and each of the following variables: CMD subtype, age, gender, race, ambulatory status, and NIPPV status. The response variable was DFVC as defined above.
The current cut-off point for recommending a sleep study is either when FVCpp is <60%, or when ÀDFVC is >20% even with normal FVCpp. Because these cutoffs were determined by expert opinion, 2 we queried our sample to see how many patients were using NIPPV and what their PFT result was for DFVC, specifically. To do this, we counted the number of individuals using NIPPV identified at four different DFVCs: <À10%, À10 to À14%, À15 to À20%, and >À20%. We also calculated the positive predictive value of the current guideline of ÀDFVC of >20% for need for NIPPV by using McNemar's test for the all subjects and by disease subtype. Table 2 shows the range of FVCpp for COL6-RD and LAMA2-RD in both sitting and supine participants. Participants with COL6-RD had a statistically significant difference in mean FVC(L) when comparing sitting to supine, whereas LAMA2-RD participants did not (Table 3) . Because there was a significant difference in age between the two subtypes, a sensitivity analysis was performed by excluding subjects over 21 years of age. This removed the significant difference in age between the two groups, however, COL6-RD remained the only group with a significant difference between sitting and supine mean FVC(L).
RESULTS
FVC (L)
FVC (PP)
For all participants, the mean sitting FVCpp was 64.67% and the mean supine FVCpp was 57.04%. There was no significant difference in the mean sitting FVCpp or mean supine FVCpp between the two disease subgroups. As with mean FVC(L), participants with COL6-RD had a statistically significant difference in mean FVC(L) when comparing sitting to supine, whereas LAMA2-RD participants did not (see Table 4 and Fig. 1) . We repeated the sensitivity analysis by excluding subjects over 21 years of age as described above, and the results did not change. FVCpp sitting correlated inversely (i.e., decreased) with age in individuals 18 years only (Table 5) . The range of volumes FVC(L) and FVC percent predicted (FVCpp) was larger for subjects with COL6-RD than for subjects with LAMA2-RD, in both sitting and supine positions. The only category where subjects with LAMA2-RD had a larger range was in DFVC because the DFVC actually increased for at least one subject with LAMA2-RD. Partial Eta 2 is a measure of effect size. Covariates included diagnosis (P < 0.0001), ambulatory status, and ventilation status. We repeated the analysis by the specific disease subtypes. The total population showed a significant difference in FVC (L) between sitting and supine positions. Controlling for disease subtype, only subjects with COL6-RD showed a significant difference in FVC(L) between sitting and supine positions. Ã Indicates statistical significance for 95%CI.
FVCpp correlated negatively with age (Table 5) .
DFVC
In general, a decrease in DFVC of up to approximately 10% in moving from the sitting to supine position is expected because of upward pressure on the diaphragm from the abdominal contents and displacement of air due to blood pooling in the thorax. 18, 19 In contrast, when analyzing the within subject differences between sitting and supine in our cohort, almost twice as many subjects with COL6-RD experienced a >20% decrease in FVC from sitting to supine compared to subjects with LAMA2-RD (Fig. 2) . DFVC did not correlate with age, even when adjusting for FVCpp sitting as the "baseline value" by partial correlation (data not shown). We performed a sensitivity analysis to see if this changed in participants 18 only, but did not find this to be the case.
DFVC and Ambulatory and NIPPV Status
We also examined the relationships between participants' decrease of >20% DFVC and ambulatory status and NIPPV status (Figs. 3 and 4) .
Logistic regression of >20% decrease in DFVC on covariates CMD subtype and ambulatory status further showed the CMD subtype was significantly associated with >20% decrease DFVC but ambulatory status was not. When controlling for ambulant status, the odds for participants with COL6-RD to have DFVC >À20% were 5.4 times greater than for those with LAMA2-RD and 17.6 times greater for a DFVC >À15%.
Logistic regression of >20% decrease on the covariates subtype and NIPPV status showed neither of the Partial Eta 2 is a measure of effect size. There was a significant difference in FVC percent predicted (FVCpp) in the total population between sitting and supine positions. Covariates included diagnosis (P ¼ 0.0021), ambulatory status, and ventilation status. Because disease subtype was the only significant covariate, we repeated the analysis by the specific disease subtypes, and only COL6-RD participants had a significant decrease in mean FVCpp between sitting and supine positions. Ã Indicates statistical significance for 95%CI. There was a negative correlation between age and FVC percent predicted (FVCpp). Older children (and adults) presented with lower FVCpp. The correlation was only statistically significant for the population that was 18 years of age. covariates were statistically significant (i.e., neither the subtype nor NIPPV status was associated with a significant postural difference in FVC). This was also only the case in participants 18 years of age.
To analyze whether any covariates (CMD subtype, age, gender, race, ambulatory status, and NIPPV status) contributed to DFVC, we performed a linear regression of DFVC while controlling for FVCpp sitting ("baseline") and identified gender as the only significant covariate (P ¼ 0.019), suggesting females experienced a greater DFVC than males. Of those participants with a relatively high sitting FVCpp (>60%), DFVC did not differ by NIPPV status (Fig. 3) .
DFVC Cut Off Points
We evaluated the numbers of individuals with a decrease of <10%, À10 to À14%, À15 to À20%, and >20% in DFVC (Table 6 ). There were equal numbers of individuals in NIPPV with a decrease of <10% as there were with a decrease of >20% (four individuals in each category). However, more LAMA2-RD individuals were prescribed NIPPVat a milder decrease in DFVC of <10%. In contrast, COL6-RD individuals were usually prescribed NIPPV with a ÀDFVC of >10%. On the other hand, only 4/19 (21%) individuals with a ÀDFVC of >20% were treated with NIPPV. Of note, 12 COL6-RD individuals had an FVCpp sitting of <60%, of which only 3 (25%) were using NIPPV. For LAMA2-RD, nine individuals had an FVCpp sitting of <60%, and four (44%) were using NIPPV.
The positive predictive value of 4FVC À20% for need for NIPPV was low for all groups: the proportion of NIPPV users among all individuals who had 4FVC À20% was 0.15, among COL6-RD who had 4FVC À20% was 0.11, and among LAMA2-RD who had 4FVC À20% was 0.19 (Fig. 4) .
DISCUSSION
Progressive respiratory failure in CMD is an important cause of morbidity and mortality related to the early onset of muscle weakness affecting respiratory muscles, related thoracic, and spinal deformities, increasing stiffness and contractures of the ribcage, and decreased respiratory compliance. [6] [7] [8] [9] [10] Systematic screening, timely recognition, and institution of appropriate intervention when necessary are among the most important components of In the COL6-RD cohort 4/30 participants (13%) were using NIPPV, 13/30 (43%) had a ÀDFVC >20%, and 3 of those 13 (23%) were using NIPPV.
In the LAMA2-RD cohort, 4/21 (19%) were using NIPPV, 5/21 (%) showed a ÀDFVC >20% and 1 of those 5 (20%) was using NIPPV. More LAMA2-RD than COL6-RD were started using NIPPV before having a ÀDFVC >20% because they had a sitting FVCpp of <60%. Fig. 3 . DFVC and ambulation status in both disease subtypes.
Comparison of ambulation and DFVC in subjects with COL6-RD to subjects with LAMA2-RD. More subjects with COL6-RD were ambulatory than subjects with LAMA2-RD. The only ambulatory subjects with a ÀDFVC of >20% were those with COL6-RD. Fig. 2 . Percent of patients with >À20% DFVC by disease subtype. Almost twice as many subjects with COL6-RD experienced a >20% decrease in FVC from sitting to supine compared to subjects with LAMA2-RD.
care in an individual with CMD. NIPPV use is recommended when day-or night-time hypoventilation have been detected as it improves symptoms such as morning headaches and daytime fatigue, reduces the frequency of intercurrent respiratory infections, and, once initiated, is used long term to manage progressive respiratory failure. 1, 2, 5 Failure to intervene may lead to significant morbidity and mortality. 2, 26 It is likely that the relative importance of the various contributors to respiratory failure and the resulting natural history of respiratory impairment differ between the various genetic subtypes of CMD. Moreover, disproportionate diaphragmatic involvement may have an additional negative impact on prognosis in neuromuscular disease. 27, 28 This is the first study to our knowledge to present dynamic spirometry results specifically in LAMA2-RD and the first to compare dynamic spirometry findings in individuals with LAMA2-RD and COL6-RD. Upon initial analysis, disease subtype was a contributing factor to having a significant decrease in FVCpp when moving from the sitting to supine position. However, we identified the change was only significant for the COL6-RD group of subjects. Participants with COL6-RD were 5.4 times more likely than LAMA2-RD participants to have a >20% decrease in DFVC when controlling for ambulant status and 17.6 times greater for a DFVC >À15%. This is an important finding regarding disease specificity, as the decrease in FVCpp between sitting and supine was seen in COL6-RD, but not in LAMA2-RD, indicating differences in pathophysiology. There appears to be to early disproportionate diaphragmatic involvement in COL6-RD specifically, consistent with the observation that nocturnal hypoventilation may be observed in children and adults who are still ambulant. 7 Use of a maximal voluntary maneuver (sniff) showed the same finding in early severe, moderateprogressive, and mild individuals. 7 In the first mouse model of COL6-RD, the diaphragm also appeared to be the most affected muscle.
29,30
Although we did not observe a significant decrease in FVCpp between sitting and supine positions in participants with LAMA2-RD, this lack of differential does not imply lack of diaphragmatic involvement in these individuals. Rather, it is reasonable to assume that the diaphragmatic contribution to respiratory compromise in LAMA2 is not as disproportionate as it is in COL6-RD but rather correlates more with the overall skeletal muscle weakness in the patient. In contrast, the disproportionate diaphragmatic weakness compared to other muscles in COL6-RD is supported clinically by the finding that ambulatory COL6-RD individuals sometimes require NIPPV whereas this is not the case in ambulant LAMA2-RD. 4 Additional factors that may differentiate the respiratory physiology in the two subtypes remain to be explored.
We also found that FVCpp sitting correlated inversely (i.e., decreased) with age in individuals 18 years only, suggesting a significantly greater progressive rate of decline in lung function in childhood. We attribute this at least in part to the fact that some younger patients have a more severe early onset clinical presentation and the older patients are more likely to represent the milder disease form. This finding is consistent with the predictable and progressive decline in FVC documented for COL6-RD by our group in a large international cohort, 4 which has also been observed by others, 17 and substantiates that the degree and time course of respiratory compromise is directly correlated with the overall severity of the disease.
Of those participants with a relatively high sitting FVCpp (>60%), DFVC did not differ by NIPPV status, suggesting that nocturnally NIPPV-dependent individuals did not have a greater drop in FVC from sitting to supine. In most cases, this is likely because both parameters decline and thus the differential between FVCpp sitting and supine did not widen. Of potential relevance to future studies, supine FVCpp has been shown to be a highly correlated predictor of transdiaphragmatic pressure (Pdi), with a cutoff of supine FVCpp of <75% being 100% sensitive and specific for predicting an abnormally low Pdi. 31 Notably, in contrast to FVCpp we did not find that DFVC worsens with age, meaning the differential is established early and remains similar with declining FVCpp. Being ambulant or having NIPPV did not decrease the likelihood of a >20% decrease in DFVC in our study, but our findings suggest females experienced a greater DFVC than males. On the other hand, Chen et al. showed that DFVC in a mixed population of neuromuscular patients using NIPPV exceeded DFVC in those with spontaneous breathing by 14-fold (P ¼ 0.001). 21 We speculate that this difference in findings may be due to Fig. 4 . DFVC and NIPPV status in both disease subtypes. There were three subjects with COL6-RD and one with LAMA2-RD on NIPPV who had a ÀDFVC of >20%. However, there wer 14 subjects (10 with COL6-RD and four with LAMA2-RD) with a ÀDFVC of >20%, who had not been started on NIPPV.
the fact that we only included two neuromuscular disease subtypes in our study whereas Chen et al., 21 included more, and FVC varies greatly between subtypes. Although Lyager et al. 32 showed a correlation between FVC <30% sitting in individuals with Duchenne muscular dystrophy needing mechanical ventilation but did not find this correlation in individuals with spinal muscular atrophy, the positive predictive value of 4FVC À20% for NIPPV was low in our total cohort and in both disease subtypes. We therefore agree with Chen et al., 21 that a prospective longitudinal study to assess the predictive value of DFVC would help identify a threshold value for initiating NIPPV, but add that these thresholds may be disease and/or gender specific.
Limitations of the current study include the small numbers in each CMD subtype, but given the rare nature of CMD, even this limited sample size has provided useful information and insights. Also, the data were collected and analyzed retrospectively and thus matching of subjects between the two CMD subtypes by age, gender, race ambulatory status, and NIPPV status was not possible. Despite this, there were no significant differences between the two groups with regard to race, gender, or NIPPV status. The difference in age between the two subtypes was a limitation, but we performed sensitivity analyses to overcome this difference, which supported our finding that only COL6-RD individuals had significant change in sitting to supine FVCpp. Furthermore, 28/51 subjects (55%) were not able to meet ATS criteria, primarily due to (1) an inability to exhale on the FVC maneuver for more than 3 sec (if a child) and more than 6 sec (if an adult) and (2) the difference between the two largest FEV1 values was >0.15 L. 33 Nevertheless, when the analysis was repeated with only those individuals who met ATS criteria, COL6-RD remained the only group with a significant difference between sitting and supine mean FVC. Finally, we did not have detailed retrospective data about degrees of scoliosis in our cohort, which may be a contributing factor to respiratory failure in this population and, although a complex factor to isolate in regard to its contribution, may be an important one to consider in future studies.
In our cohort, only 4/18 participants (22%) with a ÀDFVC >20% were using NIPPV and only 7/21 (33%) with an FVCpp sitting of <60% were using NIPPV, despite current recommendations. 2 This may be due to multiple factors such as a high "baseline" sitting FVCpp, practice variability among clinicians, or the fact that these participants' pulmonary function may have worsened since their previous PFT. However, it does highlight the critical need for systematic screening, particularly in ambulatory COL6-RD individuals, as previous studies have confirmed that nocturnal hypoventilation requiring nocturnal respiratory support can manifest while an individual with COL6-RD is still ambulant. 4, 16, 17 Adherence to the current recommendations is crucial to reduce morbidity and mortality in individuals with COL6-RD and LAMA2-RD.
